Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. (Q42981153)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 June 2012

Language	Label	Description	Also known as
English	Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.	scientific article published on 11 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Hung-Yu Sun

1

1 reference

Europe PubMed Central

12 November 2017

Chun-Chieh Lin

2

1 reference

Europe PubMed Central

12 November 2017

Jin-Ching Lee

3

1 reference

Europe PubMed Central

12 November 2017

Shainn-Wei Wang

4

1 reference

Europe PubMed Central

12 November 2017

Pin-Nan Cheng

5

1 reference

Europe PubMed Central

12 November 2017

I-Chin Wu

6

1 reference

Europe PubMed Central

12 November 2017

Ting-Tsung Chang

7

1 reference

Europe PubMed Central

12 November 2017

Ming-Derg Lai

8

1 reference

Europe PubMed Central

12 November 2017

Dar-Bin Shieh

9

1 reference

Europe PubMed Central

12 November 2017

Kung-Chia Young

10

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

11 June 2012

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

62

1 reference

Europe PubMed Central

12 November 2017

8

1 reference

Europe PubMed Central

12 November 2017

1193-1203

1 reference

Europe PubMed Central

12 November 2017

The etiology of hepatocellular carcinoma and consequences for treatment

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Hepatitis C and steatosis: a reappraisal

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Abnormalities of lipid metabolism in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Identification and characterization of a novel 5 bp deletion in a putative insulin response element in the lipoprotein lipase gene.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Apolipoprotein C1 Association with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Development of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Antiprotozoal activity of 1-phenethyl-4-aminopiperidine derivatives

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Study of effectiveness of bezafibrate in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Identification of apolipoprotein C-III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2011-301798

21 January 2018

Identifiers

10.1136/GUTJNL-2011-301798

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42981153&oldid=1590629421"